The amount of cytoplasmic receptor for the steroid hormone, estradiol (Ez), was determined in 46 nuclei and subdivisions of rat brain. Individual nuclei were removed from 300~pm frozen sections according to the punch-out method of Palkovits (Palkovits, M. (1973) Brain Res. 59: 449-450), and the content of Ea receptor was measured with a sensitive radioligand binding method. Cytoplasmic receptors for Ez were distributed heterogeneously throughout the rat brain. The highest level of receptor (40 fmol/mg of protein) was found in the periventricular nucleus of the preoptic area, while low (1 fmol/mg) but detectable levels of receptors were found in such limbic regions as the nucleus of the diagonal band, the olfactory tubercle, and the cingulate cortex. Regions that were devoid of detectable receptor included the medial septum, the parietal cortex, and the ventral thalamus. Our results support the notion that Ez influences reproductive behavior and neuroendocrine function by binding to receptors in discrete areas of the brain and provide the first quantitative map of Ez receptors in individual rat brain nuclei. The brain, like peripheral organs, possesses specific intracellular receptors for the steroid hormone, 17P-estradiol (Ez) (Eisenfeld and Axelrod, 1965; McEwen and Pfaff, 1970; McEwen, 1978). These are high molecular weight molecules that move from the cytoplasm of brain cells into nuclei after Ez binds to them (Lieberburg et al., 1980). While it has been shown from gross biochemical studies that the highest concentration of Ez receptors are found in the hypothalamus and amygdala (McEwen et al., 1975) and it has been shown by in vivo autoradiography that the receptors are distributed heterogeneously within these regions (Pfaff and Keiner, 1973; Stumpf, 1968), the amount of Ea receptor within individual hypothalamic and limbic nuclei has never been determined by direct biochemical methods. It is important to establish both the location and relative concentration of EZ receptors in the brain because there is compelling evidence that they mediate the actions of Ez on behavior and neuroendocrine function. For example, the effects of Ez on sexual behavior or on gonadotropin secretion are correlated with the degree and duration of occupation of Ez on neural receptors (Parsons et al
The brain, like peripheral organs, possesses specific intracellular receptors for the steroid hormone, 17P-estradiol (Ez) (Eisenfeld and Axelrod, 1965; McEwen and Pfaff, 1970; McEwen, 1978) . These are high molecular weight molecules that move from the cytoplasm of brain cells into nuclei after Ez binds to them (Lieberburg et al., 1980) . While it has been shown from gross biochemical studies that the highest concentration of Ez receptors are found in the hypothalamus and amygdala (McEwen et al., 1975) and it has been shown by in vivo autoradiography that the receptors are distributed heterogeneously within these regions (Pfaff and Keiner, 1973; Stumpf, 1968) , the amount of Ea receptor within individual hypothalamic and limbic nuclei has never been determined by direct biochemical methods. It is important to establish both the location and relative concentration of EZ receptors in the brain because there is compelling evidence that they mediate the actions of Ez on behavior and neuroendocrine function. For example, the effects of Ez on sexual behavior or on gonadotropin secretion are correlated with the degree and duration of occupation of Ez on neural receptors (Parsons et al., 1981 (Parsons et al., , 1982a and Parsons, 1982; McGinnis et al., 1981) , and steroid and nonsteroid antagonists of receptor binding will block the actions of Ez on the brain (Arai and Gorski, 1968; Roy and Wade, 1977; Labhsetwar, 1970) . In this study, we have used a sensitive radioligand binding assay to measure the amount of Ez receptor in individual nuclei of rat brain. Cytoplasmic receptors for En are found in a variety of brain regions in concentrations ranging from 1 to 40 fmol/mg of protein.
Materials and Methods Animals. We assayed E:, receptor levels in brain tissue from female Sprague-Dawley rats (180 to 220 gm; Charles River Laboratories, Wilmington, MA). The rats were ovariectomized 1 to 3 weeks before use. The animals were housed under a 12:12-hr light-dark cycle.
Microdissection of nuclei and subregions. The procedure of Palkovits (1973) was used to remove nuclei and subregions from 300-pm-thick frozen sections of rat brain. Rats were perfused through the heart with 20 ml of ice cold 10% dimethyl sufoxide (DMSO), a cryoprotective agent that has been shown to protect steroid receptors from damage caused by freezing (MacLusky et al., 1982) . The brains were blocked on both ends with a razor blade and frozen onto cryostat chucks in powdered dry ice. Coronal sections were cut in the Kijnig and Klippel(1963) anatomical plane using an American Optical cryostat. The microtome temperature of the cryostat was -15°C.
The sections were thaw-mounted briefly onto glass slides and were stored at -40°C for 24 to 72 hr before experimental use. Using a 500-or 1000~pm hollow stainless steel tube, brain regions were removed from portions of 27 separate 300~pm-thick sections. These sections were cut consecutively starting from the A8380 level of the Konig and Klippel atlas (1963) . The microdissection was done with the aid of a stereomicroscope. During the dissection, the temperature of the sections was maintained at -15"C with a Cambion thermoelectrically cooled plate. The location of the nuclei and brain regions was determined from the stereotaxic atlas of K&rig and Klippel (1963) and from the stereotaxic atlas of Palkovits (1980) . The location of the microdissected regions within the 27 serially cut sections and the cannula sizes used for removal are given in Table I . In some cases, brain regions were removed with a small scalpel. In preliminary measurements on 32-pm cresyl violet-stained sections, the diameter of the punch cannula did not exceed the size of the removed nuclei.
Estrogen receptor assay. We pooled tissue from three rats to obtain material for one assay. After removal from the frozen sections, the tissue samples were blown into ice cold plastic tubes. containing 24 ~1 of TEGD buffer (10 mM Tris-HCl, 5 mM EDTA, 10% glycerol, and 1 mM dithiothreitol, pH 7.4). The tissue was homogenized at moderate speed with a motor-driven homogenizer (10 strokes, up and down), and the cytosol fraction of the homogenate was obtained by centrifugation in a Beckman Airfuge at 100,000 X g for 20 min. One hundred microliters of the cytosol was added to 50 ~1 of TEGD buffer that contained either sufficient [3H]estradiol ([2,-4,6,7-3H(N) ]estradio1, 115 or 140 Ci/mmol, New England Nuclear) to make a final concentration of 1 nM [3H]Ez or 1 nM C3H]E2 along with 1 PM moxestrol to determine nonspecific binding. Aliquots of the cytosol were incubated with [3H]E2 for 4 hr at 4°C in plastic microcentrifuge tubes. The [3H]E~ bound to receptors was separated from free ligand by gel filtration at 4°C on Sephadex LH-20 columns. The columns were made from l-ml plastic disposable micropipete tips, which were filled to 5/s of the total volume with Sephadex LH-20 (Pharmacia) equilibrated with 10 mM Tris-HCl, 5 mM EDTA, and 10% glycerol, pH 7.4 (TEG buffer). The columns were stoppered with a glass bead. The columns were first washed with 200 ~1 of TEGD. At 15 min after the TEGD wash, 100~~1 aliquots of the incubates were applied to the columns and were washed onto the column bed with an additional 100 ~1 of TEGD. At 30 min after the samples were applied, the r3H]E2 bound to receptors was eluted from the columns with 400 ~1 of TEG buffer. The radioactivity in the eluate was measured by liquid scintillation counting using Liquiscint scintillation fluid (National Diagnostics, Somerville, NJ) at 32% efficiency. The protein content of the incubate was determined by the dyebinding method of Bradford (1976) . All results were expressed as femtomoles of Ez specifically bound to receptors per mg of protein.
To evaluate any loss of receptors caused by freezing, we used Scatchard analysis to compare EZ receptors from DMSO-perfused and frozen samples of mediobasal hypothalamus-preoptic area (MBH-POA) to unperfused tissue assayed immediately after sacrifice. The MBH-POA samples were removed as described (McEwen et al., 1975 
Results
Scatchard analysis and linearity. Scatchard analysis revealed that there was a moderate loss in the number of Ea receptors in frozen, DMSO-perfused MBH-POA as compared to unfrozen tissue (B,,, for unfrozen tissue, 23.6 + 4.3; B,,, for frozen tissue, 15.1 + 2.6), but there was no change in the affinity of receptors after freezing (fresh Kd, 0.44 f 0.01 nM; frozen Kd; 0.48 + .03 nM, mean f SEM, n = 3). This indicated that substantial amounts of E2 receptor was preserved during the freezing and thawing process. In preliminary studies, we observed only slightly higher levels (10 to 20%) of Ez receptor in samples microdissected from DMSO-perfused tissue compared to samples from unperfused frozen tissue. This indicated that the DMSO perfusion had only a slightly protective effect on freezing-induced loss in our samples in contrast to its larger cryoprotective action on pituitary Ez receptors and neural progestin receptors (MacLusky et al., 1982; Parsons et al., 1982) .
The amount of Ez receptor was proportional to the amount of cytosol protein over concentrations from 5 to 200 pg. The protein content of all nuclei and subregions was within this range (Table I ). In areas with moderate amounts of receptor, about 40 pg of cytosol protein (120 pg of homogenate protein) was needed to obtain reliable measurements of Ez binding (20 pg for total binding and 20 pg for nonspecific binding). It was sufficient to use only 10 pg of cytosol protein in regions with a high density of receptor. Depending on the density of receptor, the amount of specific binding for [3H]E~ ranged from 20 to 80% of the total binding.
Distribution of Ez receptor in brain regions. There were significant levels of cytoplasmic Ez receptors in most of the 46 brain regions that we examined (Table  II) . In agreement with previous biochemical and autoradiographic studies (McEwen and Pfaff, 1970; Pfaff and Keiner, 1973) , the highest levels of receptor were found in nuclei of the mediobasal hypothalamus and preoptic area. There were low to moderate levels of Ez receptors in certain regions of the limbic system and diencephalon, and there were also regions of the rat brain, such as the caudate-putamen, that lacked measurable amounts of Ez receptor. Mediobasal hypothalamus-preoptic area. The highest concentration of cytoplasmic EZ receptors in the brain was found in the nuclei of the preoptic area. Within the POA, the amount of EZ receptor was greatest in the periventricular nucleus (30 to 40 fmol/mg of protein), followed by the medial preoptic nucleus (20 fmol/mg) and the suprachiasmatic preoptic nucleus (13 fmol/mg). By contrast, the lateral preoptic nucleus had low levels of Ez binding (2 fmol/mg). There were moderate (6 fmol/ mg) levels of receptor dorsal to the POA, in the bed nucleus of the stria terminalis, while there was no de-Vol. 2, No. 10, Oct. 1982 tectable receptor immediately lateral to the bed nucleus in the caudate-putamen.
There were high levels of Ez receptor (18 fmol/mg) immediately caudal to the POA in the periventricular nucleus of the anterior hypothalamus (PVAH) with moderate (6 fmol/mg) but significantly lower levels of receptor lateral to the PVAH in the anterior hypothalamic nucleus. There were moderate levels of Eg binding lateral and dorsal to the anterior hypothalamus in the supraoptic and paraventricular nuclei. We also observed high levels (13 fmol/mg) of Ez receptor immediately caudal to the PVAH in pooled tissue from the arcuate nucleus and median eminence. There were also high levels of Ez receptor immediately lateral to the arcuate in the ventromedial nucleus (VMN).
The dorsomedial nucleus, immediately above the VMN, had moderate levels of Ez receptor (5 fmol/ mg) as did the lateral nucleus of the hypothalamus. The ventral premammillary nucleus, immediately caudal to the VMN, also had moderate levels of receptor.
Limbic regions. There were low (1 to 3 fmol/mg) but detectable levels of EP receptor immediately rostra1 to the POA in the nucleus of the diagonal band of Broca. The olfactory tubercle, immediately lateral to the diagonal band, also had a low but significant amount of Ez receptor (2 fmol/mg). There were detectable numbers of binding sites in the lateral septum but no measurable Ea receptor in the medial septum. The cingulate cortex had low but significant amounts of Ea receptor, while there was no apparent receptor in the neighboring parietal cortex. We observed relatively high amounts of Ea receptor in the medial amygdaloid nucleus (10 fmol/mg), while moderate (3 fmol/mg) but significantly lower amounts of receptor were present in the cortical nucleus of the amygdala. In the hippocampus, there were low but significant amounts of receptor in the dentate gyrus and the ventral subiculum. There was no detectable Ea receptor in the CA1 and CA3 hippocampal subfields nor in the dorsal subiculum. Diencephalon and midbrain. The midline reuniens nucleus of the thalamus had a low level of Ez binding, while there was no detectable receptor in the rhomboid nucleus immediately dorsal to the reuniens. The ventral thalamic nucleus also lacked measurable Ea receptors. The level of Ea receptor in the habenula approached statistical significance (p = 0.056), while no significant receptor was observed in the central grey, an area that shows moderate labeling in [3H]Ez autoradiography (Pfaff and Keiner, 1973) .
Subregions of MBH-POA nuclei. The high level of EP binding in particular MBH-POA nuclei enabled us to assay the amount of receptor in their anatomical subregions (Table III) . The bed nucleus of the stria terminalis (Nst) extended over two, 300~pm-thick coronal sections, corresponding roughly to Konig and Klippels (1963) levels A7190 and A6860. There was no significant difference between the amount of receptor in the rostra1 portion of the Nst (the first 300~pm section) and the caudal portion of the nucleus (the second 300~pm section). Similarly, the medial preoptic nucleus (MPOA) and the periventricular preoptic nucleus (PVPOA) also extended over two, 300~pm sections. There was no difference in the amount of Ez receptor in the rostra1 and caudal portions Table II with the highest concentration of E? receptor were subdivided into rostra1 and caudal portions or, in the case of the VMN, into medial and lateral portions as well (N = 4 for all regions). The rostra1 bed nucleus was removed from section 3 (Table I) ; its caudal portion was removed from section 4. The rostra1 medial preoptic nucleus and periventricular preoptic nucleus were removed from section 4; their caudal portions were removed from section 5. The rostra1 periventricular anterior hypothalamus was taken from sections 6 and 7; its caudal portion was removed from sections 8 and 9. The rostra1 VMN was taken from sections 10 to 12; the caudal VMN was removed from sections 13 and 14. The medial and lateral portions of the VMN were removed from sections 10 to 14. The sizes of the punch cannulas used were the same as in Table I of the PVPOA, and although it appeared that there was more receptor in the caudal portion of the MPOA than in the rostra1 portion, this difference did not reach statistical significance. The PVAH and the VMN are large nuclei that extend over four and five 300~pm sections, respectively. There was no difference in the amount of E2 receptor in the first three sections of the VMN, compared to the last two sections. However, the rostral two sections of the PVAH had significantly more receptor than the caudal sections. It is also possible to divide the VMN into medial and lateral portions. In agreement with [3H]Ez autoradiography (Pfaff and Keiner, 1973) , there were high levels of E2 receptor in the lateral portion of the VMN and no significant receptor in its medial portion.
Discussion
Our biochemical measurements of the amount of Ez receptor in rat brain nuclei and subregions are in good agreement with the general pattern of labeling obtained with ["H]Ez autoradiography (Stumpf, 1968; Pfaff and Keiner, 1973) . Pfaff and Keiner (1973) observed large numbers of labeled cells in the periventricular region extending rostrally through the POA and caudally through the arcuate nucleus. They found less uptake of [3H]Ez in nuclei lateral to the periventricular region, and there were also many labeled cells in the ventrolateral portion of the VMN and medial nucleus of the amygdala, while less intense but consistent labeling was seen in the diagonal band of Broca, lateral septum, and olfactory tubercle. These observations agree with our measurements (Tables II and III ; Fig. 1 ).
There are also several discrepancies between our results and the autoradiographic studies. There is a moderate (8 fmol/mg) level of soluble Ez receptor in the supraoptic nucleus (SON), while no Ez labeling was observed in the SON with autoradiography (Pfaff and Keiner, 1973) . Similarly, there was only a moderate amount of receptor in the caudal portion of the Nst, which, in [3H]Ez autoradiograms, appears as intensely labeled as the PVPOA. In addition, there was no detectable Ez receptor in the central grey, a region which shows moderate but reliable labeling of some cells in autoradiography.
There are several possible explanations for the discrepancies between the autoradiographic and biochemical measurements. First, we are measuring only cytoplasmic receptors for Ea, while the autoradiographic studies are visualizing both cytoplasmic receptors and nuclear receptors translocated from the cytoplasm by the in uiuo administration of [3H]Ez (Pfaff and Keiner, 1973) . Since only half of the cytoplasmic receptors in pooled MBH-POA tissue move into nuclei in response to ES (Lieberburg et al., 1980) , it is possible that regional differences in the ability of Ez receptors to translocate into nuclei might account for some of the differences between the biochemical and autoradiographic measurements. For example, it is conceivable that the Ez receptors in the SON do not translocate as extensively into nuclei in response to the steroid as in the VMN. It is also possible that the amount of cytoplasmic Ez receptor varies considerably within individual cells so that a biochemically small level of receptor might be concentrated in a few cells, which appear labeled in autoradiography. This could explain why scattered labeled cells appear in the central grey, while no detectable receptor is seen by biochemical assay. We also observed a moderate loss in Ez receptors from large samples of MBH-POA during freezing and cannot exclude the possibility that the extent of the loss differs among nuclei and subregions.
The high levels of E2 receptor in particular MBH-POA nuclei, such as the MPOA or the VMN, supports the notion that these regions are important target sites for the actions of E2 on behavior and neuroendocrine function. It is known that direct implants of Ez into the nuclei of the MBH-POA with the highest levels of receptor (MPOA and VMN) will duplicate many of the actions of peripherally administered steroid on reproductive or nonreproductive behaviors (Davis et al., 1979; Rubin and Bar-field, 1980; Wade and Zucker, 1970) or on gonadotropin secretion (Goodman, 1978) . The ablation of these nuclei (Pfaff and Sakuma, 1979 (Jackson, 1972; Rainbow et al., 1980 ) also will impair the same behavioral and neuroendocrine effects of Ez. The functional significance of the moderate and low levels of EZ receptors in particular brain regions is more obscure. The presence of moderate levels of Ez receptor in the supraoptic and paraventricular nuclei might provide an explanation for the actions of Ez on the secretion of oxytocin and vasopressin (Skowsky et al., 1979; Yamaguchi et al., 1979) , the peptide hormones synthesized by these nuclei. The presence of a low level of Ea receptor in subregions of the hippocampus is consistent with the observed changes in hippocampal electrical activity after direct application of E:, to hippocampal slices maintained in vitro (Teyler et al., 1980) . These receptors also might mediate a sexually divergent effect of EZ that could explain the sexually dimorphic pattern of axonal sprouting observed in the hippocampus (Loy and Milner, 1980) . The possible functions of the low and moderate levels of Ea receptors in such regions as the ventral premammillary nucleus or the olfactory tubercle are less apparent. It may be that these receptors mediate currently unknown actions of Ez on the brain.
An important aspect of our study is that it provides a method for the relatively rapid quantification of EZ receptors in individual brain nuclei and subregions. Thus, alterations in whole hypothalamic or limbic ES receptor levels (Roy and Wilson, 1981; Camp-Grossman and Wise, 1981; Phelps et. al., 1981) now can be localized to particular nuclei or subregions. It is also feasible to make quantitative comparisons in the amount of Ez receptor in nuclei of male or female brains (Lieberburg et al., 1980; Nordeen and Yahr, 1981) or between different species. We have used the same methodology to measure the levels of cytoplasmic progestin receptors in nuclei and subregions of rat brain (Parsons et al., 1982b) , and it should be possible to extend the method to quantitate receptors for other steroid hormones in neural tissue. It also may be feasible to measure nuclear receptors for steroid hormones in frozen punch-out samples. It is likely that the further biochemical analysis of the receptors for Ez and other steroid hormones at or below the level of individual nuclei will clarify further how steroid hormones affect the brain.
